| Name | 1,5-dihydro-4,1-benzoxazepin-2-one |
|---|---|
| Synonyms |
3,5-Dihydrobenzo[e][1,4]oxazepin-2(1H)-one
1,5-dihydro-benzo[e][1,4]oxazepin-2-one 3,5-Dihydro-4,1-benzoxazepin-2(1H)-on 1,5-dihydro-4,1-benzoxazepin-2(3H)-one QC-8827 |
| Molecular Formula | C9H9NO2 |
|---|---|
| Molecular Weight | 163.17300 |
| Exact Mass | 163.06300 |
| PSA | 41.82000 |
| LogP | 1.24040 |
| HS Code | 2934999090 |
|---|
|
~66%
3693-08-1 |
| Literature: NEUROCRINE BIOSCIENCES, INC. Patent: WO2008/124614 A1, 2008 ; Location in patent: Page/Page column 42-43 ; WO 2008/124614 A1 |
|
~%
3693-08-1 |
| Literature: Bristol-Myers Squibb Company Patent: US2007/93470 A1, 2007 ; Location in patent: Page/Page column 62 ; US 20070093470 A1 |
|
~%
3693-08-1 |
| Literature: Testa,E.; Fontanella,L. Farmaco, Edizione Scientifica, 1965 , vol. 20, p. 323 - 335 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |